Radiation Oncology: Modern Review of Treatment Toxicity

Article Sidebar

6-july-2491.pdf
Published Jul 10, 2021
DOI: https://doi.org/10.18103/mra.v9i7.2491

Downloads

Download data is not yet available.

Main Article Content

Kevin O’Connor, BS
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
James Shen, BS
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Ameer Elaimy, PhD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Linda Ding, PhD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
John Roubil, BA
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Kara Benson, BA
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Julie Trifone, RT (T) CMD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Maureen Britton, RN, CMD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Carla Bradford, PhD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
I-Lin Kuo, PhD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Yankua Fan, PhD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Fenghong Liu, PhD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Suhong Lu, PhD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Harry Bushe, MS
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Jonathan Saleeby, MS
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Abdulnasser Khalifeh, PhD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Camelia Bunaciu, MSc
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Maryann Bishop, MS
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655
Thomas J. FitzGerald, MD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester Ma. 01655

Abstract

Radiation therapy has undergone an extraordinary transformation in treatment technology. Daily patient care is vastly different today than the past with less normal tissue in the treatment field and fewer acute sequelae during and immediately post therapy. It is anticipated that modern therapy will decrease acute effects during treatment. Modern primary care physicians and internal medicine/emergency physicians will encounter more patients in their practice who are survivors of therapy. In this paper we review current expectations for clinical sequelae of management and strategies to both identify and manage treatment effects moving forward including what is needed in the medical record for evaluation of late effects.

Article Details

How to Cite
O’CONNOR, Kevin et al. Radiation Oncology: Modern Review of Treatment Toxicity. Medical Research Archives, [S.l.], v. 9, n. 7, july 2021. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/2491>. Date accessed: 20 apr. 2024. doi: https://doi.org/10.18103/mra.v9i7.2491.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 9 No 7 (2021): Vol.9 Issue 7, July, 2021
Section
Research Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Withers HR, Taylor JM, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 1988;14(4):751-759.
2. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109-122.
3. Niemierko A. A generalized concept of Equivalent Uniform Dose (EUD). Med Phys. 1999;26(6)1100.
4. Bentzen SM, Constine LS, Deasy JO, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S3-9.
5. Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S10-9.
6. Kalapurakal JA, Gopalakrishnan M, Walterhouse DO, et al. Cardiac-sparing whole lung IMRT in patients with pediatric tumors and lung metastasis: Final report of a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2019;103(1):28-37.
7. Mendenhall NP, Fitzgerald TJ. Conventional radiation therapy compared with stereotactic conformal therapy-A rare and laudable randomized trial. JAMA Oncol. 2017;3(10):1376-1377.
8. Ding Z, Zhang H, Lv X-F, et al. Radiation-induced brain structural and functional abnormalities in presymptomatic phase and outcome prediction. Hum Brain Mapp. 2018;39(1):407-427.
9. Lin J, Lv X, Niu M, et al. Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy. Neuroimage Clin. 2017;14:610-621.
10. Peters LJ, O’Sullivan B, Giralt J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol. 2010;28(18):2996-3001.
11. Yusuf SW, Venkatesulu BP, Mahadevan LS, Krishnan S. Radiation-induced cardiovascular disease: A clinical perspective. Front Cardiovasc Med. 2017;4:66.
12. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987-998.
13. Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42(1):1-9.
14. Graham MV. Predicting radiation response. Int J Radiat Oncol Biol Phys. 1997;39(3):561-562.
15. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45(2):323-329.
16. Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury: Assessment and management. Chest. 2019;156(1):150-162.
17. Käsmann L, Dietrich A, Staab-Weijnitz CA, et al. Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review. Radiat Oncol. 2020;15(1):214.
18. Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2000;18(11):2210-2218.
19. Dawson LA, Ten Haken RK, Lawrence TS. Partial irradiation of the liver. Semin Radiat Oncol. 2001;11(3):240-246.
20. Baradaran-Ghahfarokhi M. Radiation induced kidney injury. J Ren Inj Prev. 2021;1(2):49-50.
21. Lukez A, O’Loughlin L, Bodla M, Baima J, Moni J. Positioning of port films for radiation: variability is present. Med Oncol. 2018;35(5):77.
22. Oh D, Huh SJ. Insufficiency fracture after radiation therapy. Radiat Oncol. 2014;32(4):213-220.

Most read articles by the same author(s)